Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes
Substituted imidazo[4,5-b]pyridines and benzimidazoles are prepared by reacting imidazo[4,5-b]pyridines or benzimidazoles with appropriately substituted benzyl halides. The substituted imidazo[4,5-b]pyridines or benzimidazoles can be employed as active ingredients in medicaments, in particular for t...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | HANKO, RUDOLF H STASCH, JOHANNES-PETER KAZDA, STANISLAV, DR MUELLER-GLIEMANN, MATTHIAS ZAISS, SIEGFRIED FEY, PETER KRAEMER, THOMAS BEUCK, MARTIN WOHLFEIL, STEFAN KNORR, ANDREAS MUELLER, ULRICH E DRESSEL, JUERGEN HUEBSCH, WALTER |
description | Substituted imidazo[4,5-b]pyridines and benzimidazoles are prepared by reacting imidazo[4,5-b]pyridines or benzimidazoles with appropriately substituted benzyl halides. The substituted imidazo[4,5-b]pyridines or benzimidazoles can be employed as active ingredients in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GR3036287TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GR3036287TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GR3036287TT33</originalsourceid><addsrcrecordid>eNrjZAgNLk0qLsksKS1JTVHIzM1MSazK1zDRMdVN0iyoLMpMycxLLVZIzEtRSErNq4LK54CEQKLpmfklqXnFmXkKnp5Abklien5eZnFJajEPA2taYk5xKi-U5mZQdHMNcfbQTS3Ij08tLkhMTs1LLYl3DzI2MDYzsjAPCTE2JkYNANS2OZs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes</title><source>esp@cenet</source><creator>HANKO, RUDOLF H ; STASCH, JOHANNES-PETER ; KAZDA, STANISLAV, DR ; MUELLER-GLIEMANN, MATTHIAS ; ZAISS, SIEGFRIED ; FEY, PETER ; KRAEMER, THOMAS ; BEUCK, MARTIN ; WOHLFEIL, STEFAN ; KNORR, ANDREAS ; MUELLER, ULRICH E ; DRESSEL, JUERGEN ; HUEBSCH, WALTER</creator><creatorcontrib>HANKO, RUDOLF H ; STASCH, JOHANNES-PETER ; KAZDA, STANISLAV, DR ; MUELLER-GLIEMANN, MATTHIAS ; ZAISS, SIEGFRIED ; FEY, PETER ; KRAEMER, THOMAS ; BEUCK, MARTIN ; WOHLFEIL, STEFAN ; KNORR, ANDREAS ; MUELLER, ULRICH E ; DRESSEL, JUERGEN ; HUEBSCH, WALTER</creatorcontrib><description>Substituted imidazo[4,5-b]pyridines and benzimidazoles are prepared by reacting imidazo[4,5-b]pyridines or benzimidazoles with appropriately substituted benzyl halides. The substituted imidazo[4,5-b]pyridines or benzimidazoles can be employed as active ingredients in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011031&DB=EPODOC&CC=GR&NR=3036287T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011031&DB=EPODOC&CC=GR&NR=3036287T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HANKO, RUDOLF H</creatorcontrib><creatorcontrib>STASCH, JOHANNES-PETER</creatorcontrib><creatorcontrib>KAZDA, STANISLAV, DR</creatorcontrib><creatorcontrib>MUELLER-GLIEMANN, MATTHIAS</creatorcontrib><creatorcontrib>ZAISS, SIEGFRIED</creatorcontrib><creatorcontrib>FEY, PETER</creatorcontrib><creatorcontrib>KRAEMER, THOMAS</creatorcontrib><creatorcontrib>BEUCK, MARTIN</creatorcontrib><creatorcontrib>WOHLFEIL, STEFAN</creatorcontrib><creatorcontrib>KNORR, ANDREAS</creatorcontrib><creatorcontrib>MUELLER, ULRICH E</creatorcontrib><creatorcontrib>DRESSEL, JUERGEN</creatorcontrib><creatorcontrib>HUEBSCH, WALTER</creatorcontrib><title>Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes</title><description>Substituted imidazo[4,5-b]pyridines and benzimidazoles are prepared by reacting imidazo[4,5-b]pyridines or benzimidazoles with appropriately substituted benzyl halides. The substituted imidazo[4,5-b]pyridines or benzimidazoles can be employed as active ingredients in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAgNLk0qLsksKS1JTVHIzM1MSazK1zDRMdVN0iyoLMpMycxLLVZIzEtRSErNq4LK54CEQKLpmfklqXnFmXkKnp5Abklien5eZnFJajEPA2taYk5xKi-U5mZQdHMNcfbQTS3Ij08tLkhMTs1LLYl3DzI2MDYzsjAPCTE2JkYNANS2OZs</recordid><startdate>20011031</startdate><enddate>20011031</enddate><creator>HANKO, RUDOLF H</creator><creator>STASCH, JOHANNES-PETER</creator><creator>KAZDA, STANISLAV, DR</creator><creator>MUELLER-GLIEMANN, MATTHIAS</creator><creator>ZAISS, SIEGFRIED</creator><creator>FEY, PETER</creator><creator>KRAEMER, THOMAS</creator><creator>BEUCK, MARTIN</creator><creator>WOHLFEIL, STEFAN</creator><creator>KNORR, ANDREAS</creator><creator>MUELLER, ULRICH E</creator><creator>DRESSEL, JUERGEN</creator><creator>HUEBSCH, WALTER</creator><scope>EVB</scope></search><sort><creationdate>20011031</creationdate><title>Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes</title><author>HANKO, RUDOLF H ; STASCH, JOHANNES-PETER ; KAZDA, STANISLAV, DR ; MUELLER-GLIEMANN, MATTHIAS ; ZAISS, SIEGFRIED ; FEY, PETER ; KRAEMER, THOMAS ; BEUCK, MARTIN ; WOHLFEIL, STEFAN ; KNORR, ANDREAS ; MUELLER, ULRICH E ; DRESSEL, JUERGEN ; HUEBSCH, WALTER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GR3036287TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2001</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HANKO, RUDOLF H</creatorcontrib><creatorcontrib>STASCH, JOHANNES-PETER</creatorcontrib><creatorcontrib>KAZDA, STANISLAV, DR</creatorcontrib><creatorcontrib>MUELLER-GLIEMANN, MATTHIAS</creatorcontrib><creatorcontrib>ZAISS, SIEGFRIED</creatorcontrib><creatorcontrib>FEY, PETER</creatorcontrib><creatorcontrib>KRAEMER, THOMAS</creatorcontrib><creatorcontrib>BEUCK, MARTIN</creatorcontrib><creatorcontrib>WOHLFEIL, STEFAN</creatorcontrib><creatorcontrib>KNORR, ANDREAS</creatorcontrib><creatorcontrib>MUELLER, ULRICH E</creatorcontrib><creatorcontrib>DRESSEL, JUERGEN</creatorcontrib><creatorcontrib>HUEBSCH, WALTER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HANKO, RUDOLF H</au><au>STASCH, JOHANNES-PETER</au><au>KAZDA, STANISLAV, DR</au><au>MUELLER-GLIEMANN, MATTHIAS</au><au>ZAISS, SIEGFRIED</au><au>FEY, PETER</au><au>KRAEMER, THOMAS</au><au>BEUCK, MARTIN</au><au>WOHLFEIL, STEFAN</au><au>KNORR, ANDREAS</au><au>MUELLER, ULRICH E</au><au>DRESSEL, JUERGEN</au><au>HUEBSCH, WALTER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes</title><date>2001-10-31</date><risdate>2001</risdate><abstract>Substituted imidazo[4,5-b]pyridines and benzimidazoles are prepared by reacting imidazo[4,5-b]pyridines or benzimidazoles with appropriately substituted benzyl halides. The substituted imidazo[4,5-b]pyridines or benzimidazoles can be employed as active ingredients in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_GR3036287TT3 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T09%3A20%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HANKO,%20RUDOLF%20H&rft.date=2001-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGR3036287TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |